Dubai Telegraph - Who should get paid for nature's sequenced genes?

EUR -
AED 4.308835
AFN 74.49196
ALL 95.752485
AMD 433.698247
ANG 2.100015
AOA 1077.060107
ARS 1634.062666
AUD 1.619899
AWG 2.111883
AZN 1.991476
BAM 1.958911
BBD 2.358165
BDT 143.658162
BGN 1.957131
BHD 0.442705
BIF 3484.13359
BMD 1.173268
BND 1.495075
BOB 8.089849
BRL 5.759602
BSD 1.17087
BTN 111.500038
BWP 15.911271
BYN 3.314593
BYR 22996.060933
BZD 2.35476
CAD 1.595434
CDF 2716.116648
CHF 0.915365
CLF 0.026988
CLP 1062.183556
CNY 8.013834
CNH 8.000259
COP 4358.938548
CRC 532.648236
CUC 1.173268
CUP 31.091613
CVE 110.440404
CZK 24.380163
DJF 208.492911
DKK 7.47298
DOP 69.761094
DZD 155.38575
EGP 63.060593
ERN 17.599026
ETB 184.261902
FJD 2.563476
FKP 0.866879
GBP 0.863766
GEL 3.156259
GGP 0.866879
GHS 13.124845
GIP 0.866879
GMD 85.648623
GNF 10275.319526
GTQ 8.935325
GYD 244.949034
HKD 9.19332
HNL 31.122562
HRK 7.53602
HTG 153.233369
HUF 360.376445
IDR 20420.267455
ILS 3.43574
IMP 0.866879
INR 111.62728
IQD 1536.981624
IRR 1544021.234685
ISK 143.209371
JEP 0.866879
JMD 184.242619
JOD 0.831829
JPY 183.53262
KES 151.589327
KGS 102.567717
KHR 4696.459037
KMF 493.360307
KPW 1055.94532
KRW 1706.712534
KWD 0.361378
KYD 0.975658
KZT 544.048709
LAK 25711.054095
LBP 105065.228965
LKR 374.668251
LRD 214.84305
LSL 19.594087
LTL 3.464356
LVL 0.709699
LYD 7.42786
MAD 10.821086
MDL 20.208268
MGA 4880.796414
MKD 61.7262
MMK 2463.519483
MNT 4198.666619
MOP 9.45069
MRU 46.750649
MUR 54.885322
MVR 18.132862
MWK 2030.224454
MXN 20.305407
MYR 4.635602
MZN 74.97463
NAD 19.594087
NGN 1602.415095
NIO 43.070698
NOK 10.817069
NPR 178.399098
NZD 1.973918
OMR 0.451147
PAB 1.17086
PEN 4.104719
PGK 5.091086
PHP 72.05921
PKR 326.276691
PLN 4.243201
PYG 7094.32786
QAR 4.278502
RON 5.235247
RSD 117.384344
RUB 88.582143
RWF 1711.918913
SAR 4.401895
SBD 9.423995
SCR 16.802622
SDG 704.5479
SEK 10.819729
SGD 1.492673
SHP 0.875963
SLE 28.891716
SLL 24602.847529
SOS 669.162781
SRD 43.970569
STD 24284.28737
STN 24.538973
SVC 10.244358
SYP 129.682209
SZL 19.589779
THB 38.039123
TJS 10.94718
TMT 4.112306
TND 3.390157
TOP 2.824949
TRY 53.075266
TTD 7.936673
TWD 36.97966
TZS 3051.592546
UAH 51.453219
UGX 4420.019989
USD 1.173268
UYU 47.135018
UZS 14108.552463
VES 579.000876
VND 30880.424682
VUV 139.061086
WST 3.186516
XAF 657.000465
XAG 0.015467
XAU 0.000252
XCD 3.170816
XCG 2.110069
XDR 0.817098
XOF 656.445742
XPF 119.331742
YER 279.934303
ZAR 19.371072
ZMK 10560.814925
ZMW 22.099287
ZWL 377.791951
  • RBGPF

    0.0800

    63.18

    +0.13%

  • CMSC

    0.0099

    22.88

    +0.04%

  • RYCEF

    0.1500

    16.5

    +0.91%

  • GSK

    -0.5200

    50.38

    -1.03%

  • VOD

    -0.3100

    15.74

    -1.97%

  • RELX

    -0.2000

    36.16

    -0.55%

  • NGG

    0.1400

    87.64

    +0.16%

  • RIO

    1.8700

    100.5

    +1.86%

  • BTI

    1.0500

    59.4

    +1.77%

  • AZN

    -2.2200

    181.24

    -1.22%

  • BCC

    -2.2000

    72.13

    -3.05%

  • BCE

    0.1700

    24.1

    +0.71%

  • CMSD

    0.0400

    23.29

    +0.17%

  • JRI

    0.1100

    13.04

    +0.84%

  • BP

    -0.4400

    46.5

    -0.95%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Sharma--DT